AptarGroup nasal spray tech joins ENA respiratory’s Phase II trial of INNA?051
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
AptarGroup acquired Voluntis and 80% of Weihai Hengyu Medical Products in 2021.
Sommaplast’s portfolio includes closures, droppers, dispensers and dosing cups, supporting a broad range of oral dosing applications
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
APF Futurity is made from polyolefin materials with no metal parts or recycling disruptors
Subscribe To Our Newsletter & Stay Updated